There was also a borderline correlation between FGFR-1 expression and bulky disease (P=0.07), with 39% of the patients with lymphomas that expressed FGFR-1 having bulky disease compared to 12.5% of patients with lymphomas who did not. Here, FGFR1 is linked to lymphoma.